A Novel Network Pharmacology Strategy to Decode Mechanism of Lang Chuang Wan in Treating Systemic Lupus Erythematosus

Yao Gao,Ke-xin Wang,Peng Wang,Xiao Li,Jing-jing Chen,Bo-ya Zhou,Jun-sheng Tian,Dao-gang Guan,Xue-mei Qin,Ai-ping Lu
DOI: https://doi.org/10.3389/fphar.2020.512877
IF: 5.6
2020-10-02
Frontiers in Pharmacology
Abstract:Complex disease is a cascade process which is associated with functional abnormalities in multiple proteins and protein-protein interaction (PPI) networks. One drug one target has not been able to perfectly intervene complex diseases. Increasing evidences show that Chinese herb formula usually treats complex diseases in the form of multi-components and multi-targets. The key step to elucidate the underlying mechanism of formula in traditional Chinese medicine (TCM) is to optimize and capture the important components in the formula. At present, there are several formula optimization models based on network pharmacology has been proposed. Most of these models focus on the 2D/3D similarity of chemical structure of drug components and ignore the functional optimization space based on relationship between pathogenetic genes and drug targets. How to select the key group of effective components (KGEC) from the formula of TCM based on the optimal space which link pathogenic genes and drug targets is a bottleneck problem in network pharmacology. To address this issue, we designed a novel network pharmacological model, which takes Lang Chuang Wan (LCW) treatment of systemic lupus erythematosus (SLE) as the case. We used the weighted gene regulatory network and active components targets network to construct disease-targets-components network, after filtering through the network attribute degree, the optimization space and effective proteins were obtained. And then the KGEC was selected by using contribution index (CI) model based on knapsack algorithm. The results show that the enriched pathways of effective proteins we selected can cover 96% of the pathogenetic genes enriched pathways. After reverse analysis of effective proteins and optimization with CI index model, KGEC with 82 components were obtained, and 105 enriched pathways of KGEC targets were consistent with enriched pathways of pathogenic genes (80.15%). Finally, the key components in KGEC of LCW were evaluated by <i>in vitro</i> experiments. These results indicate that the proposed model with good accuracy in screening the KGEC in the formula of TCM, which provides reference for the optimization and mechanism analysis of the formula in TCM.
pharmacology & pharmacy
What problem does this paper attempt to address?
The problem that this paper attempts to solve is how to screen out the key group of effective components (KGEC) from traditional Chinese medicine compound prescriptions, especially for Lang Chuang Wan (LCW), a Chinese medicine compound prescription for treating systemic lupus erythematosus (SLE). Specifically, the paper proposes a new network pharmacology strategy, aiming to optimize and capture the important components in LCW to explain its mechanism for treating SLE. The key to this problem lies in how to select the key component group that can effectively intervene in SLE based on the relationship between pathogenic genes and drug targets in a complex multi - component and multi - target system. The main contributions of the paper include: 1. **Construction of a weighted gene regulatory network**: By integrating protein - protein interaction (PPI) data from multiple public databases and gene data related to SLE, a weighted gene regulatory network of SLE was constructed. 2. **Selection of active components**: 1,693 components were collected from 16 herbs in LCW, and 193 potential active components were screened out using three ADME (absorption, distribution, metabolism, excretion) - related models (oral bioavailability OB, Caco - 2 permeability and drug - likeness DL). 3. **Definition of optimization space**: A disease - target - component network was constructed through the weighted gene regulatory network and the active component - target network, and then the optimization space was defined to screen out effective proteins. 4. **Contribution Index model (CI)**: Using the dynamic 0 - 1 knapsack algorithm, the effective components were optimized based on the contribution index model, and finally 82 key effective components (KGEC) were determined. 5. **Experimental verification**: The biological activities of the key components in KGEC were verified by in vitro experiments, and the results showed that these components had significant effects in inhibiting inflammation and regulating immunity. In conclusion, through an innovative network pharmacology method, this paper successfully screened out the key group of effective components in LCW for treating SLE, providing an important reference for understanding the treatment mechanism of LCW.